KOLQ Oral Drop
By KOLQ
Rx
15ml Drop in a Packet

Composition
Cetirizine(2.5mg) + Phenylephrine(1mg)

Manufacturer - Blue Cross Laboratories Ltd
Peninsula Chambers, Peninsula Corporate Park, G.K Marg, Lower Parel (West), Mumbai - 400013, Maharashtra, INDIA.

Expires on or after
July, 2026

liver
When it comes to the liver, the use of KOLQ Oral Drop appears to be safe for patients with liver disease. Based on the limited data available, it is indicated that adjusting the dose of KOLQ Oral Drop may not be necessary for individuals with liver issues. However, it is always recommended to consult with your doctor before using this product to ensure its suitability for your specific situation.

kidney
KOLQ Oral Drop should be used carefully in patients with kidney disease. Consult your doctor for possible dose adjustments. Avoid in severe kidney disease. End-stage kidney disease patients may experience excessive sleepiness.

alcohol
When using KOLQ Oral Drop, caution is advised when consuming alcohol. It is recommended to consult your doctor regarding alcohol consumption.

driving
When taking KOLQ Oral Drop, your driving ability is usually unaffected.

pregnancy
KOLQ Oral Drop may not be safe during pregnancy as animal studies have indicated potential harm to the baby. Consult your doctor for advice on its use during this period.

breastfeeding
KOLQ Oral Drop may not be safe to use while breastfeeding. Limited evidence indicates the drug can pass into breastmilk and harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹39
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025